<code id='7809A2D8B8'></code><style id='7809A2D8B8'></style>
    • <acronym id='7809A2D8B8'></acronym>
      <center id='7809A2D8B8'><center id='7809A2D8B8'><tfoot id='7809A2D8B8'></tfoot></center><abbr id='7809A2D8B8'><dir id='7809A2D8B8'><tfoot id='7809A2D8B8'></tfoot><noframes id='7809A2D8B8'>

    • <optgroup id='7809A2D8B8'><strike id='7809A2D8B8'><sup id='7809A2D8B8'></sup></strike><code id='7809A2D8B8'></code></optgroup>
        1. <b id='7809A2D8B8'><label id='7809A2D8B8'><select id='7809A2D8B8'><dt id='7809A2D8B8'><span id='7809A2D8B8'></span></dt></select></label></b><u id='7809A2D8B8'></u>
          <i id='7809A2D8B8'><strike id='7809A2D8B8'><tt id='7809A2D8B8'><pre id='7809A2D8B8'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:2591
          Adobe

          It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

          Or is there?

          advertisement

          A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          FDA's Pazdur wants cancer trials to range beyond China alone
          FDA's Pazdur wants cancer trials to range beyond China alone

          RichardPazdur,right,alsospokeabouttheFDA'suseofacceleratedapproval.MeganBearderPhotographyCHICAGO— T

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

          AlastairGrant/APLONDON— AstraZenecasaidThursdayitwouldpurchasetheFrenchfirmAmolytPharmainadealworthu